Ownership history in Frazier Life Sciences Management, L.P. · 6 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in LEXEO THERAPEUTICS INC (LXEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 4,424,725 | — | 0% | 1.18% | $43.9M | $9.93 |
| 2025 Q3 | UNCHANGED | 4,424,725 | — | 0% | 0.88% | $29.4M | $6.64 |
| 2025 Q2 | ADDED | 4,424,725 | +3,469,210 | +363.1% | 0.71% | $17.8M | $4.02 |
| 2025 Q1 | UNCHANGED | 955,515 | — | 0% | 0.15% | $3.3M | $3.47 |
| 2024 Q4 | REDUCED | 955,515 | -295,271 | -23.6% | 0.26% | $6.3M | $6.58 |
| 2024 Q3 | INITIATED | 1,250,786 | — | — | 0.45% | $11.3M | $9.04 |
As of 2025 Q4 — sorted by position size